Navigation Links
Ohio Injury Lawyers Support FDA's Decision for Further Testing of Transvaginal Mesh
Date:1/10/2012

MAYFIELD HEIGHTS, Ohio, Jan. 10, 2012 /PRNewswire/ -- Transvaginal mesh will undergo new safety studies, as required by the FDA. The product defect lawyers at Elk & Elk are currently investigating transvaginal mesh claims.

The Food and Drug Administration is requiring more than 30 transvaginal surgical mesh manufacturers, including Johnson & Johnson, Boston Scientific Corp. and C.R. Bard Inc., to perform post-market safety studies after a fivefold increase in the number of complications linked to these devices.

The manufacturers will study side effects of the devices, including mesh erosion, pain and infection. They must provide data on the effectiveness of transvaginal mesh implants for treating conditions like pelvic organ prolapse and stress urinary incontinence in women.

Approximately 300,000 women underwent transvaginal mesh procedures in 2010, according to the FDA, and many manufacturers are now facing lawsuits for complications involving transvaginal mesh. The Ohio injury lawyers at Elk & Elk are investigating claims for transvaginal surgical mesh injuries.

In July 2011, the FDA issued a safety communication alerting patients of the risks of transvaginal surgical mesh. The alert came after transvaginal mesh was linked to a much higher rate of complications than claimed by manufacturers.

"Now these companies are going to have to tell the truth," said Lana Keeton in an article in Bloomberg Businessweek. Keeton is a mesh recipient and patient advocate from Austin, Texas. "Up until now, there's been no data. It's all been marketing."

Transvaginal surgical mesh hasn't been adequately tested as a safe and effective treatment for POP or SUI. Elk & Elk's product defect lawyers support the FDA's deci
'/>"/>

SOURCE Elk & Elk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
3. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
4. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
5. Helping Families Cope After an Injury
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. Novel Approach May Protect Against Heart Attack Injury
10. For Iraq Veterans, Headaches Continue After Traumatic Brain Injury
11. Orthopaedic Injury: High Risk to Pregnant Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... MONTREAL , Nov. 21, 2014 /PRNewswire/ ... that the European Medicines Agency (EMA) has ... the company,s lead product candidate, for the ... is a rare, severely disabling genetic disease ... tissue swelling (flare-ups) and new abnormal bone ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... Chief Executive Officer, will be presenting at the 26 th ... Palace Hotel in New York . The ... 2:00 PM ET. In addition, Mr. Krakauer and Jorgen ... separate one-on-one meetings during the day. An ...
(Date:11/21/2014)... November 2014 Michael DeMarco (42) ... des 14. Februar 2014 zugetragen hat. Seine Tochter Aly ... Video - http://youtu.be/5cVoMCe0uiE ... mein morgendliches Training zu machen", erzählt Michael DeMarco ... Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... be Presented, PRINCETON, N.J., Sept. 4 ... nine clinical abstracts for ipilimumab,an investigational anti-CTLA-4 antibody, ... presentations at the 33rd Congress of the European ... 2008 in Stockholm.,Many of the following abstracts will ...
... for Targeted Therapies ... Benefits of Personalized Treatment HUNTINGTON BEACH, ... leader in molecular cancer diagnostics,today announced the launch of ... determine the gene expression levels of,the estrogen receptor (ER), ...
Cached Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding dresses, ... business offers a wide range of special occasion dresses, ... them to create multiple looks easily. , According to ... of chic wedding dresses has been prepared for many ... rates now. Dylan Queen can always create what ladies ...
(Date:11/22/2014)... November 22, 2014 Nocturia is ... the complaint that the individual has to wake ... The report “Nocturia – Pipeline Review, H2 2014” ... Nocturia, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:11/22/2014)... The topic of B&D Rockeries’ latest publication is ... states that, “While they give off the appearance of simplicity ... creating this powerful look.” , One of the first and ... kind of block matches your home environment and best fulfills ... main options are concrete and stone blocks. But do not ...
(Date:11/22/2014)... St. Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that ... of the Thanksgiving #PayItForward contest. , Ms. Lombardo ... package from Kitchen Innovations. She wrote of how her ... beautiful, young daughters as a single mom. Despite medical ...
(Date:11/22/2014)... November 22, 2014 “Greenfield Naturals” was ... Tech Report , which features the latest and coolest ... expert and reporter for NewsWatch, conducted the product review ... the flavor of your water. , From pollution to ... important that everything is done to remove these chemicals, ...
Breaking Medicine News(10 mins):Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2
... Jerrold ... Connolly Medical Ltd. , ... (Vocus) January 29, 2010 -- Berkeley Heights – Jerrold S. Lozner, M.D., M.H.A., ... named as a “Top Doctor for Women’s Health” by Castle Connolly Medical, Ltd, in ...
... Pa. , Jan. 29 The Susan P. ... educate and inspire people of all ages to make healthy ... as President and CEO.  A talented non-profit leader, his goal ... expanding the delivery and distribution of health education services by ...
... , , Provides oral regime for hormone ... SPRING, Md. , Jan. 29 The U.S. ... with Femara (letrozole) to treat hormone positive and HER2-positive advanced ... indicated. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , HER2 ...
... respiratory weakness as a factor in the morbidity of ... that could improve long-term patient outcomes while reducing costs ... chair of research for the Department of Internal Medicine ... awarded a highly competitive, two-year, $480,000/year NIH Challenge Grant ...
... ... Following is the National Council on Disability,s monthly bulletin for December ... NCD,s award-winning Web site ( http://www.ncd.gov ), brings you the latest issues ... go to http://listserv.access.gpo.gov , click on "Online mailing list archives," select ...
... HANOVER TOWNSHIP, Pa. , Jan. 29 During a ... Secretary Everette James and Secretary of Education Gerald ... activity among middle school students. , "One-third of all Pennsylvania ... a lifetime of health problems," said James. "Schools like Hanover ...
Cached Medicine News:Health News:Summit Medical Group Physician Named 'Top Doctor for Women's Health' 2Health News:Susan P. Byrnes Health Education Center Names C.T. O'Donnell President and CEO 2Health News:Susan P. Byrnes Health Education Center Names C.T. O'Donnell President and CEO 3Health News:FDA Expands Use of Approved Breast Cancer Drug 2Health News:FDA Expands Use of Approved Breast Cancer Drug 3Health News:Kentucky research looks at respiratory weakness in ICU morbidity 2Health News:National Council on Disability Monthly Bulletin for January 2010 2Health News:National Council on Disability Monthly Bulletin for January 2010 3Health News:National Council on Disability Monthly Bulletin for January 2010 4Health News:National Council on Disability Monthly Bulletin for January 2010 5Health News:National Council on Disability Monthly Bulletin for January 2010 6Health News:National Council on Disability Monthly Bulletin for January 2010 7Health News:National Council on Disability Monthly Bulletin for January 2010 8Health News:National Council on Disability Monthly Bulletin for January 2010 9Health News:State Health, Education Leaders Applaud Luzerne County School for Boosting Physical Activity Among Students 2
... your camera upon arrival.,Our technician then makes note ... with a thorough customer quote. We respect that ... so well help you prioritize repairs. With customer ... , ISI uses only OEM or widely approved ...
... carefully inspects your equipment upon arrival. Our technician ... and provides you with a thorough customer quote. ... a tight budget so well help you prioritize ... repair begins., , ISI uses only OEM or ...
... Infinity™ AST single liquid stable reagent ... quantitative determination of AST in serum. ... only provides excellent stability and convenience ... against existing assays. The reagent is ...
... Konelab 30 is a fully automated, versatile ... analytical needs in mind. Konelab 30 is ... tests, specific proteins, therapeutic drugs, drugs of ... applications. Its flexibility also makes the analyzer ...
Medicine Products: